• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢早衰。

Premature ovarian insufficiency.

机构信息

Department of Endocrinology and Reproductive Medicine, AP-HP Pitié Salpêtrière Hospital, Sorbonne Université Médecine, Paris, France.

Inserm U1151 INEM, Necker Hospital, Paris, France.

出版信息

Nat Rev Dis Primers. 2024 Sep 12;10(1):63. doi: 10.1038/s41572-024-00547-5.

DOI:10.1038/s41572-024-00547-5
PMID:39266563
Abstract

Premature ovarian insufficiency (POI) is a cause of infertility and endocrine dysfunction in women, defined by loss of normal, predictable ovarian activity before the age of 40 years. POI is clinically characterized by amenorrhoea (primary or secondary) with raised circulating levels of follicle-stimulating hormone. This condition can occur due to medical interventions such as ovarian surgery or cytotoxic cancer therapy, metabolic and lysosomal storage diseases, infections, chromosomal anomalies and autoimmune diseases. At least 1 in 100 women is affected by POI, including 1 in 1,000 before the age of 30 years. Substantial evidence suggests a genetic basis to POI. However, the cause of idiopathic POI remains unknown in most patients, indicating that gene variants associated with this condition remain to be discovered. Over the past 10 years, tremendous progress has been made in our knowledge of genes involved in POI. Genetic approaches in diagnosis are important as they enable patients with familial POI to be identified, with the opportunity for oocyte preservation. Moreover, genetic approaches could provide a better understanding of disease mechanisms, which will ultimately aid the development of improved treatments.

摘要

卵巢早衰(POI)是导致女性不孕和内分泌功能障碍的原因,其定义为 40 岁之前正常、可预测的卵巢功能丧失。POI 的临床特征是闭经(原发性或继发性)伴循环中卵泡刺激素水平升高。这种情况可能由于卵巢手术或细胞毒性癌症治疗、代谢和溶酶体储存疾病、感染、染色体异常和自身免疫性疾病等医疗干预而发生。至少有 1/100 的女性受到 POI 的影响,包括 1/1000 的女性在 30 岁之前受到影响。大量证据表明 POI 具有遗传基础。然而,大多数患者的特发性 POI 病因仍不清楚,这表明与这种情况相关的基因变异仍有待发现。在过去的 10 年中,我们对参与 POI 的基因的认识取得了巨大进展。诊断中的遗传方法很重要,因为它们使具有家族性 POI 的患者能够被识别出来,并有机会进行卵母细胞保存。此外,遗传方法可以提供对疾病机制的更好理解,这最终将有助于开发改进的治疗方法。

相似文献

1
Premature ovarian insufficiency.卵巢早衰。
Nat Rev Dis Primers. 2024 Sep 12;10(1):63. doi: 10.1038/s41572-024-00547-5.
2
Genes involved in the pathogenesis of premature ovarian insufficiency.参与卵巢早衰发病机制的基因。
Minerva Ginecol. 2015 Oct;67(5):421-30. Epub 2015 Jun 26.
3
Premature ovarian insufficiency in general practice: Meeting the needs of women.全科医疗中的卵巢早衰:满足女性需求
Aust Fam Physician. 2017 Jun;46(6):360-366.
4
Premature Ovarian Insufficiency: New Perspectives on Genetic Cause and Phenotypic Spectrum.卵巢早衰:遗传病因和表型谱的新视角。
Endocr Rev. 2016 Dec;37(6):609-635. doi: 10.1210/er.2016-1047. Epub 2016 Oct 3.
5
Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies.卵巢储备标志物在卵巢早衰中的表现:不同临床阶段和不同病因。
Front Endocrinol (Lausanne). 2021 Mar 18;12:601752. doi: 10.3389/fendo.2021.601752. eCollection 2021.
6
[Homozygous Variant of of the Fanconi Anemia Pathway Causes Premature Ovarian Insufficiency: Investigation of the Pathogenic Mechanism].范可尼贫血通路的纯合变异导致卵巢早衰:致病机制研究
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 May 20;55(3):559-565. doi: 10.12182/20240560207.
7
Premature ovarian insufficiency and infertility.卵巢早衰与不孕
Aust J Gen Pract. 2023 Jan-Feb;52(1-2):32-38. doi: 10.31128/AJGP-08-22-6531.
8
Position statement on the diagnosis and management of premature/primary ovarian insufficiency (except Turner Syndrome).关于诊断和管理原发性/早发性卵巢功能不全(特纳综合征除外)的立场声明。
Ann Endocrinol (Paris). 2021 Dec;82(6):555-571. doi: 10.1016/j.ando.2021.09.001. Epub 2021 Sep 8.
9
Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).目前对卵巢早衰(POI)病因、症状和治疗选择的认识。
Front Endocrinol (Lausanne). 2021 Feb 25;12:626924. doi: 10.3389/fendo.2021.626924. eCollection 2021.
10
Association study of anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms with idiopathic primary ovarian insufficiency.抗苗勒管激素和抗苗勒管激素 II 型受体多态性与特发性原发性卵巢功能不全的关联研究。
Hum Reprod. 2013 Dec;28(12):3301-5. doi: 10.1093/humrep/det384. Epub 2013 Oct 20.

引用本文的文献

1
Development of a predictive framework for ovarian reserve decline based on pelvic microbiota dysbiosis.基于盆腔微生物群失调的卵巢储备功能下降预测框架的开发
EPMA J. 2025 Aug 9;16(3):589-601. doi: 10.1007/s13167-025-00417-4. eCollection 2025 Sep.
2
Indigenous women's experiences, symptomology and understandings of menopause: a scoping review.原住民女性对更年期的经历、症状及认知:一项范围综述
BMC Womens Health. 2025 Aug 26;25(1):408. doi: 10.1186/s12905-025-03953-3.
3
The mechanism of Ningxin-Tongyu-Zishen formula regulating probdnf/mbdnf balance through PAI-1/tPA signaling pathway in the treatment of premature ovarian insufficiency.

本文引用的文献

1
Effects of chemical activation versus fragmentation on human ovarian tissue and follicle growth in culture.化学激活与分割对培养的人卵巢组织和卵泡生长的影响。
Hum Reprod Open. 2024 May 22;2024(3):hoae028. doi: 10.1093/hropen/hoae028. eCollection 2024.
2
Effects of reactive oxygen species and mitochondrial dysfunction on reproductive aging.活性氧物质和线粒体功能障碍对生殖衰老的影响。
Front Cell Dev Biol. 2024 Feb 23;12:1347286. doi: 10.3389/fcell.2024.1347286. eCollection 2024.
3
Rare diseases: challenges and opportunities for research and public health.
宁心通瘀滋肾方通过PAI-1/tPA信号通路调节probdnf/mbdnf平衡治疗卵巢早衰的机制
J Ovarian Res. 2025 Aug 14;18(1):184. doi: 10.1186/s13048-025-01769-1.
4
Female germline stem cells: recent advances, opportunities, and challenges to overcome.雌性生殖系干细胞:最新进展、机遇及有待克服的挑战
Cell Regen. 2025 Aug 12;14(1):34. doi: 10.1186/s13619-025-00256-8.
5
Abnormal uterine bleeding and fertility challenges secondary to long COVID: A case report.新冠长期症状继发的异常子宫出血和生育挑战:一例报告
SAGE Open Med Case Rep. 2025 Aug 1;13:2050313X251364093. doi: 10.1177/2050313X251364093. eCollection 2025.
6
Stress granule clearance mediated by V-ATPase-interacting protein NCOA7 mitigates ovarian aging.由V-ATP酶相互作用蛋白NCOA7介导的应激颗粒清除减轻卵巢衰老。
Nat Aging. 2025 Jul 31. doi: 10.1038/s43587-025-00927-w.
7
Urolithin A Protects Ovarian Reserve Via Inhibiting PI3K/Akt Signaling and Preventing Chemotherapy-Induced Follicle Apoptosis.尿石素A通过抑制PI3K/Akt信号通路和防止化疗诱导的卵泡凋亡来保护卵巢储备。
Biology (Basel). 2025 Jul 8;14(7):829. doi: 10.3390/biology14070829.
8
Circular RNAs as regulators and biomarkers of mammalian ovarian ageing.环状RNA作为哺乳动物卵巢衰老的调节因子和生物标志物
Geroscience. 2025 Jul 17. doi: 10.1007/s11357-025-01798-0.
9
Dominant follicle-targeted nanocarriers for GH delivery to alleviate premature ovarian insufficiency.用于递送生长激素以缓解卵巢早衰的靶向优势卵泡纳米载体
Mater Today Bio. 2025 Jun 11;33:101930. doi: 10.1016/j.mtbio.2025.101930. eCollection 2025 Aug.
10
Pregnancy after breast cancer: latest evidence and practical considerations.乳腺癌后的妊娠:最新证据与实际考量
Ther Adv Med Oncol. 2025 Jun 18;17:17588359251346648. doi: 10.1177/17588359251346648. eCollection 2025.
罕见病:研究与公共卫生面临的挑战与机遇
Nat Rev Dis Primers. 2024 Feb 29;10(1):13. doi: 10.1038/s41572-024-00505-1.
4
Bone mineral density in patients with primary ovarian insufficiency: A systematic review and Meta-Analysis.原发性卵巢功能不全患者的骨矿物质密度:一项系统评价和Meta分析。
Eur J Obstet Gynecol Reprod Biol. 2024 Apr;295:219-227. doi: 10.1016/j.ejogrb.2024.02.013. Epub 2024 Feb 10.
5
Oligogenic basis of premature ovarian insufficiency: an observational study.早发性卵巢功能不全的寡基因基础:一项观察性研究。
J Ovarian Res. 2024 Feb 3;17(1):32. doi: 10.1186/s13048-024-01351-1.
6
Premature ovarian insufficiency: a review on the role of tobacco smoke, its clinical harm, and treatment.卵巢早衰:关于烟草烟雾的作用、临床危害和治疗的综述。
J Ovarian Res. 2024 Jan 9;17(1):8. doi: 10.1186/s13048-023-01330-y.
7
Modeling delay of age at natural menopause with planned tissue cryopreservation and autologous transplantation.通过计划性组织冷冻保存和自体移植对自然绝经年龄延迟进行建模。
Am J Obstet Gynecol. 2024 Apr;230(4):426.e1-426.e8. doi: 10.1016/j.ajog.2023.12.037. Epub 2024 Jan 4.
8
Follicle development and its prediction in patients with primary ovarian insufficiency: Possible treatments and markers to maximize the ability to conceive with residual follicles.原发性卵巢功能不全患者的卵泡发育及其预测:利用残余卵泡实现受孕能力最大化的可能治疗方法和标志物。
Reprod Med Biol. 2023 Dec 22;22(1):e12556. doi: 10.1002/rmb2.12556. eCollection 2023 Jan-Dec.
9
Stratification of the risk of ovarian dysfunction by studying the complexity of intermediate and premutation alleles of the FMR1 gene.通过研究FMR1基因中间等位基因和前突变等位基因的复杂性对卵巢功能障碍风险进行分层。
Am J Med Genet A. 2024 Apr;194(4):e63479. doi: 10.1002/ajmg.a.63479. Epub 2023 Nov 21.
10
Successful pregnancy rates amongst patients undergoing ovarian tissue cryopreservation for non-malignant indications: A systematic review and meta-analysis.非恶性指征行卵巢组织冷冻保存患者的妊娠成功率:系统评价和荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2024 Jan;292:30-39. doi: 10.1016/j.ejogrb.2023.11.004. Epub 2023 Nov 6.